| Income Statement for Martek Biosciences Corp. (MATK) | | | | | | | Income | in Thousands of Dollars | | | 10/2007 | 10/2006 | 10/2005 | 10/2004 | 10/2003 | | | Operating Revenue | 306,813 | 270,654 | 217,852 | 184,493 | 114,737 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | (173,411) | (151,604) | (116,887) | (106,306) | (63,842) | | Gross Operating Profit | 133,402 | 119,050 | 100,965 | 78,187 | 50,895 | | | Selling/General/Admin Expense | (46,469) | (42,772) | (41,058) | (29,774) | (19,154) | | Research & Development | (24,853) | (24,823) | (20,468) | (18,596) | (12,218) | | EBITDA | 62,080 | 51,455 | 39,439 | 29,817 | 19,523 | | Depreciation & Amortization | (26,466) | (17,149) | (16,494) | (8,687) | (4,697) | | EBIT | 35,614 | 34,306 | 22,945 | 21,130 | 14,826 | | Interest Income | 1,144 | 1,490 | 1,428 | 579 | 717 | | Other Income, Net | - | - | - | 193 | 283 | | Total Income Avail For Interest Expense | 35,905 | 31,067 | 24,373 | 21,902 | 16,076 | | Interest Expense | (2,233) | (3,018) | (303) | - | (84) | | Pre-Tax Income | 33,672 | 28,049 | 24,070 | 21,902 | 15,992 | | Income Taxes | (1,659) | (10,238) | (8,786) | 25,146 | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | 32,013 | 17,811 | 15,284 | 47,048 | 15,992 | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | 32,013 | 17,811 | 15,284 | 47,048 | 15,992 | | | Normalized Income | 32,866 | 22,540 | 15,284 | 47,048 | 15,742 | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | (853) | (4,729) | - | - | 250 | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | 32,013 | 17,811 | 15,284 | 47,048 | 15,992 | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 10/2007 | 10/2006 | 10/2005 | 10/2004 | 10/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | 0.99 | 0.55 | 0.49 | 1.62 | 0.63 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | 0.99 | 0.55 | 0.49 | 1.62 | 0.63 | | | Diluted EPS from Continuing Operations | 0.98 | 0.55 | 0.48 | 1.55 | 0.58 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | 0.98 | 0.55 | 0.48 | 1.55 | 0.58 | | | |
